Request Offer

NeuClone Pharmaceuticals

  • NeuClone’s aim is to be the lowest cost producer of twenty of the world’s top-selling biologic drugs as their patents expire.
  • With our manufacturing partner, Serum Institute, the world’s largest vaccines producer, we are developing capacity to bring to market generic copies (+US$60bn in annual sales) making them more affordable in the West and accessible to the developing world.